Lipid-Altering Efficacy and Safety of Ezetimibe/Simvastatin Versus Atorvastatin in Patients With Hypercholesterolemia and the Metabolic Syndrome (from the VYMET Study)-Reference-Cited by-同舟云学术

Lipid-Altering Efficacy and Safety of Ezetimibe/Simvastatin Versus Atorvastatin in Patients With Hypercholesterolemia and the Metabolic Syndrome (from the VYMET Study)

Published:2009-06 Issue:12 Volume:103 Page:1694-1702
ISSN:0002-9149
Container-title:The American Journal of Cardiology
language:en
Short-container-title:The American Journal of Cardiology

Author:

Robinson Jennifer G.,Ballantyne Christie M.,Grundy Scott M.,Hsueh Willa A.,Parving Hans-Henrik,Rosen Jeffrey B.,Adewale Adeniyi J.,Polis Adam B.,Tomassini Joanne E.,Tershakovec Andrew M.

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference27 articles.

1. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute scientific statement;Grundy;Circulation,2005

2. Metabolic syndrome: connecting and reconciling cardiovascular and diabetes worlds;Grundy;J Am Coll Cardiol,2006

3. Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report;Circulation,2002

4. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines;Grundy;J Am Coll Cardiol,2004

5. AHA/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update: endorsed by the National Heart, Lung, and Blood Institute;Smith;Circulation,2006

Cited by 60 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The effect of statin therapy in combination with ezetimibe on circulating C-reactive protein levels: a systematic review and meta-analysis of randomized controlled trials;Inflammopharmacology;2022-08-21

2. Polypharmacology in Clinical Applications: Cardiovascular Polypharmacology;Polypharmacology;2022

3. The efficacy of niacin supplementation in type 2 diabetes patients;Medicine;2021-03-26

4. Dyslipidemia and Cardiometabolic Syndrome;CardioMetabolic Syndrome Journal;2021

5. Intestinally Active Therapies for Hypercholesterolemia: Ezetimibe, Bile Acid Resins, and Plant Sterols;Contemporary Cardiology;2020-12-16